Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

BACKGROUND: Risk-assessment of endometrial cancer (EC) is based on clinicopathological factors and molecular subgroup. It is unclear whether adding hormone receptor expression, L1CAM expression or CTNNB1 status yields prognostic refinement. METHODS: Paraffin-embedded tumour samples of women with hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermij, Lisa, Jobsen, Jan J., León-Castillo, Alicia, Brinkhuis, Mariel, Roothaan, Suzan, Powell, Melanie E., de Boer, Stephanie M., Khaw, Pearly, Mileshkin, Linda R., Fyles, Anthony, Leary, Alexandra, Genestie, Catherine, Jürgenliemk-Schulz, Ina M., Crosbie, Emma J., Mackay, Helen J., Nijman, Hans. W., Nout, Remi A., Smit, Vincent T. H. B. M., Creutzberg, Carien L., Horeweg, Nanda, Bosse, Tjalling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050005/
https://www.ncbi.nlm.nih.gov/pubmed/36690721
http://dx.doi.org/10.1038/s41416-023-02141-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050005/
https://www.ncbi.nlm.nih.gov/pubmed/36690721
http://dx.doi.org/10.1038/s41416-023-02141-0

Ejemplares similares